Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus <scp>ALL</scp> studyMichelina Dargenio, Robin Foà, Barbara Scappini et al.|British Journal of Haematology|2022Cited by 19
Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Aged ≥60 Years Treated with a 10-Day Decitabine Schedule Versus Intensive Chemotherapy in the AML21 Study (NCT02172872)Adriano Venditti, Francesco Buccisano, Michal Kiciński et al.|Blood|2023Cited by 1
<scp>MRD</scp> Assessment in Patients With Acute Myeloid Leukemia Aged ≥ 60 Years Treated With a 10‐Day Decitabine Schedule Versus Intensive Chemotherapy in the <scp>AML21</scp> StudyAdriano Venditti, Francesco Buccisano, Ernesta Audisio et al.|American Journal of Hematology|2025Cited by 1
P1686: LONG-TERM COMORBIDITY AND HEALTH PROBLEMS IN ACUTE MYELOID LEUKEMIA (AML) SURVIVORS: AN INTERNATIONAL AML SURVIVORSHIP STUDYFabio Efficace, Laura Cannella, Xavier Thomas et al.|HemaSphere|2023Cited by 0
Lifestyle Behaviors and Health-Related Quality of Life in Long-Term Survivors of Acute Myeloid Leukemia: An International Survivorship Study By the Gimema, EORTC Quality of Life and Leukemia GroupsFabio Efficace, Frédéric Baron, Laura Cannella et al.|Blood|2023Cited by 0